tion resulted in reproducible pneumonia and bacteraemia, and demonstrated post-stroke susceptibility to streptococcal pneumonia developing with a delay of at least 24 h after MCAO. Higher bacterial counts in mice infected 3 days after stroke induction correlated with reduced neutrophil and macrophage infiltration in the lungs and lower levels of proinflammatory cytokines in the broncho-alveolar lavage compared to sham-operated animals. Pneumonia increased mortality without affecting brain-infiltrating leukocytes.
terial pneumonia that affects up to one-third of stroke patients [6] carries the highest attributable mortality of all medical complications [7, 8] .
Important insights into the pathogenesis of post-stroke immune depression have been gained from experimental stroke models [9] [10] [11] . An important limitation is that mice develop spontaneous Gram-negative bacteraemia and pneumonia in some [10, 12, 13] but not in all studies [14] . This may not only result from the use of various stroke models [15] but also from different institutional animal housing conditions that may modulate the microbiota and thus systemic immune responses in experimental animals [16, 17] . To improve the reproducibility of findings in experimental post-stroke pneumonia, a model inducing standardized bacterial pneumonia is desirable.
Streptococcus pneumoniae is a Gram-positive, encapsulated, facultative anaerobic bacterium that is considered the most common bacterial respiratory tract pathogen [18] . Streptococcal pneumonia occurs most often in elderly patients with comorbidities [19] and is the most common cause of bacterial community-acquired pneumonia [20] . In stroke patients, Staphylococcus aureus , Klebsiella pneumoniae , and Pseudomonas aeruginosa are more frequently isolated than S. pneumoniae [21] ; however, the specific pathogen often cannot be identified [22] . On the other hand, S. pneumoniae is additionally associated with cerebrovascular diseases by triggering the rupture of atherosclerotic plaques [23] and increasing the risk for stroke [24] . S. pneumoniae induces lobar pneumonia in rodents with similar histopathological characteristics as in humans [25] that makes this bacterial strain an excellent candidate to model post-stroke pneumonia in mouse.
In this study, we present a standardized model of streptococcal pneumonia after experimental stroke and characterize the inflammatory response in the lungs as well as the impact on outcome.
Materials and Methods

Animals
The study was conducted in accordance with national guidelines for the use of experimental animals. All experimental procedures were approved by the appropriate governmental committees (Regierungspraesidium Karlsruhe, Germany). Ten-to 12-week-old, mature male mice (C57BL/6, Charles River Laboratories) weighing 20-25 g were randomly assigned to different experimental groups. All mice were housed in individually ventilated cages in groups of 3 mice per cage lined with chip bedding and environmental enrichment with nesting material (tissues). All mice were kept on a standard 12 h light/dark cycle, and had free access to food and water.
Bacterial Strain S. pneumoniae TIGR4 [26, 27] , an encapsulated strain of serotype 4 (ATCC BAA-334), was grown overnight on blood agar plates (BD Diagnostic Systems, Columbia Agar with 5% sheep blood) from frozen stocks at 37 ° C and 5% CO 2 . Colonies were inoculated into THY medium (Todd Hewitth Broth) containing 1% yeast extract, grown to mid-logarithmic phase (OD 600 = 0.3), and diluted to the required concentrations for mouse infections.
Induction of Experimental Stroke
We induced experimental stroke by advancing a nylon-monofilament to the left MCA for 60 min (online suppl. methods; for all online suppl. material, see www.karger.com/doi/10.1159/000452136).
Intra-Tracheal Inoculation with S. pneumoniae Mice were anesthetized with ketamine/xylazine (100 and 10 mg/kg, respectively, i.p.) and hung perpendicularly by the 2 front upper teeth. The 2 fibre optic arms of a halogen light source were positioned at the front of the neck to illuminate the larynx. The tongue was carefully pulled out and a Hamilton syringe with a 22 G blunt needle was advanced into the trachea approximately 3 mm under the level of the vocal cords. Twenty microliters of bacterial suspension diluted in phosphate buffered saline (PBS) or PBS alone (control) was slowly injected. Then, mice were placed under an infrared heating lamp until recovery from anaesthesia.
Bacterial concentration used for inoculation was verified by plating out 10-fold serial dilutions onto blood-agar plates. Allocation of animals to treatment groups was randomized. Inoculated animals were housed separately from PBS controls.
Assessment of S. pneumoniae Colony Forming Units in Nasal
Lavage, Broncho-Alveolar Lavage, Lungs, and Blood Bacterial counts were analysed 12, 24, 48, and 72 h after infection. After opening the chest under ketamine/xylazine anaesthesia, blood was collected by cardiac puncture and diluted 10-fold in PBS to avoid coagulation. Broncho-alveolar lavage (BAL) was collected by flushing the lungs with 1 mL of PBS using a 22 G catheter (BD Venflon Pro Safety) placed in the trachea. After obtaining BAL, lungs were removed aseptically and homogenized in 1 mL PBS. All samples were serially diluted in PBS and dilutions were plated onto blood-agar plates. After incubation overnight at 37 ° C in 5% CO 2 , colony-forming units (CFUs) on blood-agar plates were counted by evaluators who were blinded for group assignment.
Histopathology of Lungs
Lungs were perfused transcardially with PBS and filled with 4% paraformaldehyde (PFA) through the trachea. Lungs were removed and post-fixed in 4% PFA for 24 h. Serial 3 μm sections were stained with hematoxylin and eosin (H&E), and a semiquantitative scoring system [28] was used to describe tissue inflammation (online suppl. methods). Inflammatory scores were determined by a pathologist who was blinded to treatment and surgical group assignment.
Analysis of Cytokine Levels in BAL
Cytokine concentration of BAL samples was measured by Cytometric Bead Array (BD Biosciences) following the manufacturer's instructions using an LSRII flow cytometer (BD). Results were analysed using FCAP Array software (Soft Flow, Inc.).
Flow Cytometric Analysis
Leukocyte subpopulations isolated from blood, spleen, and brain were identified based on cell surface antigens using multicolor flow cytometry (online suppl. methods).
Assessment of Infarct Volume
We determined the infarct volume on 20 μm thick cresyl violet-stained cryosections after correction for brain edema (online suppl. methods).
Statistical Analysis
In each experimental setup, a priori sample size calculation was performed. In the course of experiments presented in Figure 1 , there was no difference between the 1 and 3 days sham groups. Therefore, after additional statistical consultation, the 2 sham groups were pooled to reach the calculated n = 9 group size. Student's t test was used to make comparisons between the 2 groups, and analysis of variance was used for making multiple comparisons with post hoc Tukey's test after validating the normal distribution of these datasets (Kolmogorov-Smirnov test). For analysis of ordinal histopathological scores and variables with non-normal distributions, Kruskal-Wallis test with Dunn's multiple comparison test was performed. Wilcoxon signed-rank test was performed to compare column medians to 0.0 as hypothetical value in case of identical values in one of the groups. The accepted significance level was p < 0.05 in all comparisons. The GraphPad Prism 6 software was used for statistical analysis.
Results
Establishment of S. pneumoniae Infection Model in Naive Mice
To establish a dose of S. pneumoniae suitable for investigation of post-stroke susceptibility to infection, serial 10× dilutions of the liquid bacterial culture in the midlogarithmic growth phase (OD = 0.3; ∼ 2.5 × 10 6 bacteria in 20 μL) were applied for intra-tracheal inoculation of naive mice. The CFUs were counted in BAL, lungs, and blood 24 h following infections. CFU numbers in lung homogenates and blood correlated with bacterial doses used for inoculation (online suppl. ) showed complete clearance of bacteria at 24 h. Inoculation with undiluted bacterial suspension ( ∼ 2.5 × 10 6 ) resulted in bacteraemia in all animals. In order to find an infecting bacterial dose that could differentiate clearance capacity of stroke and control animals, bacterial doses showing virulence at least in 1 but not in all mice (10× and 100× dilutions) were used for subsequent kinetics experiments.
We characterized the kinetics of bacterial clearance 12, 48, and 72 h after intra-tracheal inoculation with 2 different ( ∼ 2.5 × 10 4 and ∼ 2.5 × 10 5 ) bacterial doses in naive mice (online suppl. Fig. IB) . At 12 h, intra-tracheal injection of S. pneumoniae suspensions resulted in detectable CFUs in BAL in all animals but no bacteraemia was found. One day after inoculation, CFU numbers peaked in the lung, and bacteria appeared in the blood. Later on bacterial numbers decreased and 48 h post-infection, only the higher inoculation dose resulted in detectable CFUs in any investigated compartment. At 72 h, no bacteria were detected in BAL anymore, whereas clearance was slower in lungs and blood. For subsequent experiments, a bacterial dose of 1.25 × 10 5 CFU (i.e. between the 2 tested doses) was chosen. For all these pilot experiments, 6 mice per group were analysed.
Post-Stroke Susceptibility to Streptococcal Pneumonia Develops Over Days after Middle Cerebral Artery Occlusion
For all further experiments, sham-operated animals were used as controls for post-stroke pneumonia. To investigate the kinetics of post-stroke susceptibility to infections, mice ( n = 9/group) were inoculated with S. pneumoniae 1, 3, and 5 days after middle cerebral artery occlusion (MCAO; Fig. 1 a) . Bacterial CFU count was assessed in BAL, lungs, and blood 24 h after infection. In sham mice, CFU numbers were similar between mice inoculated 1 or 3 days after sham operation. Therefore, these animals were pooled and served as for comparison with the MCAO groups. Mice infected 1 day following MCAO showed no differences of CFU numbers compared to sham-operated animals. In contrast, when infection was performed 3 or 5 days after MCAO, animals had significantly higher CFU numbers than sham animals or mice inoculated 1 day after MCAO. Findings were similar when inoculation was performed 3 days after MCAO, and CFUs were assessed 48 h later: only sham-operated mice had cleared bacterial infection ( Fig. 1 b) .
Attenuated Pulmonary Inflammatory Reaction to S. pneumoniae after Stroke
To characterize the inflammatory tissue reaction in mice showing impaired clearance of S. pneumoniae , animals ( n = 6/group) were infected 3 days following MCAO, and 24 h later histopathological scoring was performed on H&E-stained lung sections ( Fig. 2 a) . Sham animals showed pronounced neutrophil-infiltration and goblet cell metaplasia, and increased numbers of eosinophil macrophages upon inoculation with S. pneumoniae . This cellular inflammatory response was substantially attenuated after MCAO ( Fig. 2 b) . Post-stroke susceptibility to streptococcal pneumonia develops over days after MCAO. a Experimental setup and numbers of CFU in BAL, lung and blood 24 h after infection with ∼ 1.25 × 10 5 S. pneumoniae . Intra-tracheal infection was performed at the indicated time points after sham-operation or MCAO. From 9 inoculated mice per group, n = 8 mice in 1 day, n = 9 mice in 3 days, and n = 7 mice in 5 days MCAO group were analysed due to mortality occurring between inoculation and sampling; for 1 + 3 days pooled sham group n = 4 + 5 = 9. * p < 0.05 between groups as indicated; # p < 0.05 vs. cumulated sham groups. b Experimental setup and numbers of CFU 48 h after infection with 1.25 × 10 5 S. pneumoniae . Intra-tracheal infection was performed 3 days after sham-operation or MCAO ( n = 9/group in sham and n = 10/ group in MCAO group). Dot plots display a line at mean calculated from the log 10 values of CFU counts.
# p < 0.05 vs. sham (BAL). quantitative scoring system evaluating perivascular edema, neutrophil-infiltration, goblet cell metaplasia and eosinophil macrophage number was used to determine histopathological changes ( n = 6/group). * p < 0.05 between groups as indicated. Cytokine profiles of the same animals were characterized in BAL. S. pneumoniae infection resulted in elevated levels of the pro-inflammatory cytokines interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and IL-17 in sham animals ( Fig. 3 ) . In contrast, MCAO mice had significantly lower levels of IL-6 and IL-17 compared to the infected sham group. A similar trend was detected for the expression of interferon-gamma (IFN-γ).
Stroke Induces Peripheral Leukopenia
Streptococcal pneumonia increased blood leukocyte counts in sham mice, which was mainly the result of elevated B cell counts ( Fig. 4 a) . MCAO without S. pneumoniae inoculation induced peripheral leukopenia both in blood and spleen affecting most leukocyte subpopulations, but for granulocytes, only a trend was found ( Fig. 4 ; online suppl. Fig. II) . Interestingly, S. pneumoniae inoculation significantly increased the numbers of T cells in blood of MCAO mice compared to PBS-treated MCAO animals ( Fig. 4 a) .
Besides reducing leukocyte numbers, we detected significantly reduced MHC class II expression on B cells of MCAO mice regardless of infection in both blood and spleen ( Fig. 4 b) . Similarly, CD11b expression by granulocytes was lower in MCAO compared to that in sham mice ( Fig. 4 c) . Conversely, MCAO alone or in combination with pneumococcal inoculation did not affect cell surface activation markers on T cells (CD69) and monocytes (MHC class II; data not shown).
S. pneumoniae Infection Worsens Stroke Outcome
To determine the impact of post-stroke pneumonia on outcome, mice ( n = 16/group) were inoculated with either S. pneumoniae or PBS 3 days after MCAO. As sham operation does not induce brain infarction and sham animals show complete bacterial clearance already 48 h after inoculation ( Fig. 1 b) , only MCAO mice were involved in this part of the study. Survival 1 week after MCAO was significantly higher in mice receiving PBS (75%) compared to mice inoculated with pneumococci (25%; Fig. 5 a) . In comparison with PBS-treatment, S. pneumoniae inoculation tended to increase the infarct size (58.5 ± 14.6 vs. PBS: 42.3 ± 16.7) but did not influence brain-infiltration by any leukocyte subpopulation ( Fig. 5 b) .
Discussion
In our study, we established a standardized model for the investigation of post-stroke pneumococcal pneumonia that showed the following characteristics: (1) increased susceptibility to S. pneumoniae infection with a delay of more than 24 h after stroke onset; (2) attenuated cellular and humoral inflammatory response in the lung resulting in higher frequency of bacteraemia; and (3) worsening of stroke outcome in inoculated mice.
Previous stroke studies induced streptococcal pneumonia by intra-nasal inoculation. In these models, the intensity of anaesthesia used for inoculation and animal handling (e.g., head positioning and blockage of the mouth) may largely influence the aspiration rate, resulting in a highly variable infection rate. Additionally, strokeinduced impairment of bulbar reflexes in rodents may largely differ from dysphagia described in stroke patients justifying the need for an alternative inoculation model for post-stroke pneumonia research. Applying the bacteria directly into the trachea provides a more standardized approach and thereby allows for a direct investigation of immunosuppression-induced susceptibility for pneumonia without the confounding effect of variable aspiration. Although intra-tracheal inoculation is widely used in lung research [29] [30] [31] [32] , it has been applied only by one study in the neuroimmunology field for the assessment of spinal cord injury-induced immune deficiency [33] .
Intra-tracheal inoculation can be performed via tracheotomy through a midline incision on the neck and insertion of a needle between the tracheal rings [31, 32] or by a noninvasive view-controlled intra-tracheal instillation inserting a syringe with a blunt needle directly [29, 34] or through an intubating catheter [35] into the trachea. The noninvasive approaches have a clear advantage for animal welfare and they also minimize a potential instillation into the bloodstream. Although an intubationmediated intra-tracheal injection approach may increase the confidence of inoculum-delivery, it also increases manipulation time. Considering these factors, for the present study a noninvasive intra-tracheal injection approach was used without additional intubation.
For noninvasive intra-tracheal inoculation in mice, mostly ketamine/xylazine [29, 36] or isoflurane inhalation [35, 36] are used but the results are controversial regarding the efficacy of inoculation achieved with one or the other. We chose ketamine/xylazine because it results in stable anesthesia with good analgesia and strongly suppresses bulbar reflexes facilitating the inoculation. However, to decrease the duration of anesthesia and to reduce cardiac depression, anesthesia should be reversed after inoculation by the administration of atipamezole or yohimbine. For intra-nasal inoculation with streptococcal pneumonia, a wide range of bacterial numbers between 200 and 4 × 10 7 were used in post-stroke pneumonia studies [37] [38] [39] . In this study, CFU numbers in tissue homogenates correlated well with bacterial doses used for the infection proving the reproducibility of the inoculation method. An inoculation dose in the magnitude of 10 5 was efficient to detect a difference in bacterial clearance between control and stroke animals. However, individual mouse strains may have different susceptibility for S. pneumoniae [32, 40] and may require titration prior experimentation.
In stroke patients, pneumonia develops with a mean latency of 1.8 days after admission [41] . In experimental stroke, Prass et al. [38] found increased susceptibility to S. pneumoniae aspiration when inoculated intra-nasally 4 days after stroke. In accordance with their results, we found significantly increased susceptibility to streptococcal pneumonia 3 days after stroke. We additionally showed that MCAO mice still had intact bacterial clearance 24 h after stroke and -similarly to stroke patientssusceptibility to S. pneumoniae infection only increased subsequently. This kinetics underscored the importance of the breakdown of immunological defence mechanisms as a constitutional component of post-stroke pneumonia.
Streptococcal pneumonia is characterized by a rapidly developing neutrophilic alveolitis that has a critical role in antimicrobial host defense by restraining bacterial growth at the distal airspaces, thereby preventing bacteremia [42, 43] . In addition, resident and recruited mononuclear phagocytes are important for the resolution and repair of the damaged lung tissue by phagocytosing cellular debris [44] . In the lungs of mice inoculated 3 days after stroke, we found reduced neutrophil infiltration and decreased numbers of eosinophil macrophages compared to sham-operated animals. Furthermore, inoculation with S. pneumoniae induced the production of pro-inflammatory cytokines including IL-6, TNF-α, and IL-17 in the lungs of sham-operated animals, while this response was diminished in stroke mice. These pro-inflammatory cytokines are required for the recruitment of innate immune cells into the lungs [45] [46] [47] and are important mediators of the protective inflammatory response after pneumonia [48] [49] [50] . Impaired IL-6 and IL-17 production and the reduced numbers of neutrophils and macrophages in the lung may therefore represent an important mechanism of stroke-induced susceptibility to S. pneumoniae infection in this study. We speculate that reduced infiltration of inflammatory cells into the infected lungs may also have implications for the radiographic diagnosis of pneumonia in stroke patients [51] .
The reduced infiltration and cytokine levels in the lungs of MCAO mice may be attributed to the lower leukocyte numbers found in the blood and spleen. In our previous study, we showed that stroke-induced leukocyte-loss affected at the early time points (2 and 24 h) only the lymphocyte subpopulations, while granulocyte and monocyte counts were still on the level of sham-operated controls at 24 h and were only subsequently reduced 3 days after stroke [52] . These observations may explain the delayed emergence of susceptibility to S. pneumoniae infection after stroke.
In this study, streptococcal pneumonia increased mortality after stroke, but no effect was seen on brain infiltration of leukocyte populations. Although, we observed only a trend to increased infarct size in the infected group, Denes et al. [37] showed that S. pneumoniae infection profoundly exacerbated ischemic brain injury through increasing platelet activation and microvascular coagulation. However, in that study, a repeated inoculation approach was used with higher bacterial doses that may exacerbate the effect of pneumonia on stroke outcome.
In conclusion, we present a standardized mouse model of post-stroke pneumonia induced by noninvasive intratracheal injection of 10 5 S. pneumoniae 3 days after severe stroke. This model may be highly useful for future research to investigate the mechanisms of both stroke-induced susceptibility for streptococcal pneumonia and pneumoniainduced worsening of stroke outcome. However, additional studies are required to describe these mechanisms by Gram-negative bacteria-induced pneumonia.
